Access to Medicine – Patents versus Patients
Fifa Rahman, Board Member, Unitaid NGO Delegation | Mark Cheong, Pharmacist, Monash University
Price gouging in the pharmaceutical industry has become a common feature of health news. Who can forget Martin Shkreli’s infamous price hike of the HIV drug Daraprim, which went from USD13.50 to $750 in the summer of 2015? Are international laws tough enough to ensure that the bottom line is the people and not profit?
Produced by: Tina Carmillia
Presented by: Meera Sivasothy
Download the BFM mobile app. Stay at home and stay up-to-date.